Scott Moore explores China’s trajectory in the worldwide biotechnology sector. While the United States has long been the dominant worldwide player in developing and commercializing biotechnology for many years, China is set to be a leading participant in biotechnology and is also investing greatly within the sector. Moore argues that, while the U